A Waltham biotech focused on cystic fibrosis and a Boston biotech led by serial founder Gary Glick are the first ...

The ADSs are trading on the Nasdaq under the ticker “AAPGV ... Click here to see upcoming IPO calendar on TipRanks. Beta Bionics, “a pioneering leader in the development of advanced diabetes ...

As a result, Renaissance expects a banner year for IPOs, with an estimated volume range of 155 to 195 IPOs in 2025 and $40 billion to $55 billion in new funding as the market "normalizes" in 2025. "A ...

Use our IPO calendar to view upcoming IPOs and new IPOs ... Skyline Builders Group Holding Limited (NASDAQ: SKBL) (the Company), a civil engineering services provider in Hong Kong, today ...

Use our IPO calendar to view upcoming IPOs and recent IPOs ... and SUZHOU, China, Jan. 28, 2025 (GLOBE NEWSWIRE) -- Ascentage Pharma (Nasdaq: AAPG) (HKEX: 6855) announced today the closing of its U.S.

About Nasdaq Private Market Nasdaq Private Market provides liquidity solutions for private companies, employees, and investors throughout each stage of the pre-IPO lifecycle. In 2013, the company ...

Use our IPO calendar to view upcoming IPOs and recent IPOs ... Skyline Builders Group Holding Limited (NASDAQ: SKBL) (the Company), a civil engineering services provider in Hong Kong, today ...

Ascentage Pharma IPO opens flat at $17.25 By Investing.com - Jan 24, 2025 Ascentage Pharma (Nasdaq: AAPG) IPO opens at $17.25 after pricing 7,325,000 American depositary shares at $17.25J.P. Morgan ...

NEW YORK – Anbio Biotechnology filed this week a preliminary prospectus for an initial public offering on the Nasdaq exchange of 1.6 million shares ... At the lower end of the range net proceeds from ...

Nasdaq Inc. Chief Executive Officer Adena Friedman said she expects a strong environment for initial public offerings in the second quarter and balance of 2025 as investors gain confidence from ...